Concepedia

Ming Hao

MH

Statistics

Publications

25

Citations

1K

H-Index

18

Active since

2012

Affiliations

First Affiliated Hospital of Harbin Medical University(Current)

Harbin Medical University

Peking Union Medical College Hospital

Chinese Academy of Medical Sciences & Peking Union Medical College

The First Hospital of Kunming

Ming Hao is an author at First Affiliated Hospital of Harbin Medical University specializing in medicine, pharmacology, and life sciences.

ORCID

Publications per year

2012–2024

25

Publications

25

Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy

Xinyang Yu, Ming Hao, Yu Liu et al. · European Journal of Pharmacology · 2019 · 189 citations

, , +16

Benefits of exenatide on obesity and non‐alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes

Ning Shao, Hong Kuang, Ming Hao et al. · Diabetes/Metabolism Research and Reviews · 2014 · 185 citations

, , +11

Dapagliflozin Reduces Apoptosis of Diabetic Retina and Human Retinal Microvascular Endothelial Cells Through ERK1/2/cPLA2/AA/ROS Pathway Independent of Hypoglycemic

Yuxin Hu, Xu Qian, Hongxue Li et al. · Frontiers in Pharmacology · 2022 · 71 citations · Full text

, , +17

Neuroprotective Role of GLP-1 Analog for Retinal Ganglion Cells via PINK1/Parkin-Mediated Mitophagy in Diabetic Retinopathy

Huanran Zhou, Xuefei Ma, Wenjian Lin et al. · Frontiers in Pharmacology · 2021 · 51 citations · Full text

, , +16

Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway

Ning Shao, Xinyang Yu, Xuefei Ma et al. · Gastroenterology Research and Practice · 2018 · 50 citations · Full text

, , +17

1–5 of 25